Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
13.10
-0.15 (-1.13%)
At close: Aug 8, 2025, 4:00 PM
12.95
-0.15 (-1.15%)
After-hours: Aug 8, 2025, 7:55 PM EDT
Verve Therapeutics Employees
Stoke Therapeutics had 128 employees as of December 31, 2024. The number of employees increased by 18 or 16.36% compared to the previous year.
Employees
128
Change (1Y)
18
Growth (1Y)
16.36%
Revenue / Employee
$1,491,469
Profits / Employee
$392,750
Market Cap
715.22M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 128 | 18 | 16.36% |
Dec 31, 2023 | 110 | -7 | -5.98% |
Dec 31, 2022 | 117 | 15 | 14.71% |
Dec 31, 2021 | 102 | 23 | 29.11% |
Dec 31, 2020 | 79 | 23 | 41.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
STOK News
- 2 days ago - Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates - Business Wire
- 2 days ago - Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 23 days ago - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress - GlobeNewsWire
- 4 weeks ago - Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress - Business Wire
- 7 weeks ago - Stoke Therapeutics: Impressive Pipeline And Big Backers - Seeking Alpha
- 2 months ago - Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - Business Wire